Equillium

About Equillium

Equillium is a top-tier immunobiology company focused on advancing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. Their mission is to restore immune system balance for patients seeking to improve their quality of life.

Products & Services

EQ504:A potent and selective AhR modulator with a unique, multi-modal, non-immunosuppressive mechanism of action, complementary to other inflammation and immunology agents. It supports barrier function, tissue repair, and anti-inflammatory responses.

Multi-Cytokine Inhibitor Platform:First-in-class structured-domain peptides that inhibit multiple disease-driving cytokines for applications in numerous inflammatory conditions, while preserving other immune regulatory pathways.

Itolizumab:A novel immunomodulatory asset targeting immuno-inflammatory pathways.

Specialties

Immunobiology Autoimmune Disorders Inflammatory Disorders Immunomodulatory Therapeutics Multi-Cytokine Inhibition Aryl Hydrocarbon Receptor Modulation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 50000000 MR: - FA: up to $50 million FAN: 50000000	D: 2025-08-11 FD: 2025-08-11	5 investors

Private Placement Latest

2025-08-11

$50.0M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

B

Bruce Steel

Chief Executive Officer

S

Stephen Connelly

Chief Scientific Officer

C

Christine Zedelmayer

Chief Operating Officer

P

Penny Tom

Senior Vice President, Finance & Principal Accounting Officer

J

Joel Rothman

Chief Development Officer

M

Matt Ritter

SVP Corporate Development

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

Equillium Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised